The page is the record's research on the issuer — no analyst, no rating, no view.

AIM ImmunoTech Inc. (AIM) — research page

US · us-cm-kg/NYSE/AIM · as of 2026-11-08

Identity and listing

The issuer is AIM ImmunoTech Inc., listed on NYSE under ticker AIM. The ISIN is US00901B3033 and the LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). The security type is Corporate, the segment is not on the record, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States — Delaware. The listing status is listed, not halted.

fieldvaluesource · read date
nameAIM ImmunoTech Inc.source · 2026-11-08
exchangeNYSEsource · 2026-11-08
tickerAIMsource · 2026-11-08
ISINUS00901B3033source · 2026-10-13
LEInot on the record
security typeCorporatesource · 2026-11-08
segmentnot on the record
sector2836 Biological Products, (No Diagnostic Substances)source · 2026-11-08
jurisdictionUnited States — Delawaresource · 2026-11-08
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 74 filings in the window 2025-11-08 to 2026-11-08, across 56 filing days. By type, the record holds 3 ad hoc, 6 AGM/EGM, 19 corporate news, 12 directors' dealings, 14 prospectus, 15 regulatory filing and 5 results filings. The median gap between filing days is 4 days. The latest filing is dated 2026-11-06, two days before the record date, and is of type directors' dealings. For NYSE the record holds 3256 issuers with a median cadence gap of 6.0 days, a median of 64.0 filings and a median latency of 4.0 days. For the sector on this market the record holds 176 issuers with a median cadence gap of 5.5 days, a median of 65.5 filings and a median latency of 4.0 days.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer7442
exchange median: NYSE (3256 issuers)6464
sector median: 2836 Biological Products, (No Diagnostic Substances) (176 issuers)65.55.54
datetypecategoryfiling
2026-11-06directors_dealings44 — 4
2026-11-05corporate_news8-K8-K — 8-K (items 7.01,9.01)
2026-11-03agm_egmDEFA14ADEFA14A — DEFA14A
2026-10-26directors_dealings44
2026-10-23directors_dealings44 — 4

window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is not on the record (no dei:AuditorName tag on the latest annual report cover; foreign private issuers and older filings carry none). The auditor's location is not on the record. The record holds no auditor changes.

Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag reads listed, not halted.

Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The record holds no research houses named on the issuer's investor-relations page; none was found on the pages read. The count is 0.

Open research

The record holds no openly published research notes for the issuer; none was found. The count is 0.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The issuer's sealed years are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

Sources

7 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
10.2
https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
10.3
https://data.sec.gov/submissions/CIK0000946644.json (identity.jurisdiction)
10.4
https://mcp.us-cm-kg.ai/events/NYSE/AIM (the disclosure lines)
10.5
https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
10.6
https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
10.7
https://mcp.us-cm-kg.ai/record/NYSE/AIM (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US00901B3033"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:4bc7b88e667aaa88.